Navigation Links
The Reaxys Ph.D. Prize awards innovative research in organic, organometallic and inorganic chemistry
Date:6/1/2010

rsity), Paul McGonigal (University of Edinburgh), David Michaelis (University of Wisconsin-Madison), Evan Miller (University of California, San Diego), Thomas Moss (University of Manchester), Devon Mundal (Northwestern University), Julia Neumann (Westflische Wilhelms-Universitt Mnster), Tobias Seiser (ETH Zurich), Rohit Kumar Sharma (National Institute of Pharmaceutical Education & Research), Lauren Sirois (Stanford University), Christof Sparr (ETH, Zurich), Jason Spruell (Northwestern University), Yuto Sumida (Kyoto University), Kosuke Suzuki (University of Tokyo), Giulia Tagliabue (University of Insubria), Jason Thomas (University of British Columbia), Hirofumi Ueda (Tohoku University), Akira Ueda (Osaka University), Oleg Vechorkin (Ecole Polytechnique Fdrale de Lausanne), Dieter Weber (University of North Carolina at Chapel Hill), Peter Wich (University of California, Berkeley), and Akira Yada (Kyoto University)

The final selection was made by the Regional Coordinators who are all members of the Reaxys Advisory Board:

  • Dr. P. Kocis - former Global Head Exploratory Chemistry, AstraZeneca
  • Professor H. Kunz - University of Mainz, Germany
  • Professor H. N. C. Wong - Chinese University of Hong Kong, Hong Kong, China

The winners and runners-up have been invited to attend the Reaxys PhD Prize Symposium at the 3rd EuCheMS Chemistry Congress on Monday, August 29 2010. The winners are invited to give a short oral presentation of their research, and the finalists will participate in a special poster session and reception.

The symposium will also include presentations from Dr. Graeme Robertson, VP Portfolio Management, Siena Biotech and Prof. Erick Carreira, Laboratory of Organic Chemistry, ETH, Zurich, Switzerland.

David Evans PhD, Scientific Affairs Director at Elsevier Properties SA said today, "The quality of the submissions we received was excellent. The review board had some very difficult decisions t
'/>"/>

Contact: Emma Potter
emma.potter@kaizo.net
44-020-304-34191
Elsevier
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Geraldine Dawson, Ph.D. of Autism Speaks appointed to NIH Interagency Autism Coordinating Committee
2. Marwan Khaled Tayeh, Ph.D., is awarded the 2010 Richard King Trainee Award
3. UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students
4. Ph.D. student in K-State plant pathology selected for international fellowship
5. Nanyang Technological University and Karolinska Institutet Sweden launch new Ph.D. program
6. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
7. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
8. Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
9. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
10. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
11. UTSA wins $500,000 to develop biosensor and regenerative medicine Ph.D. program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... by Northwestern Medicine® scientists helps explain how bipolar disorder ... new drug therapies to treat the mental illness. ... the same method recognized with the 2014 Nobel ... brain tissue from mice with bipolar-like behaviors. In the ... tiny "nanodomain" structures with concentrated levels of ANK3 -- ...
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2
... million years ago, when the lineage of humans and ... turnips may have been one of the reasons. According ... of Minnesota and Richard Wrangham of Harvard University, the ... tubers must have sustained our ancestors who left the ...
... all likely to blame for poisoning the waters being drained from ... is leaving behind -- also owes its contamination to a source ... environments that made their way en masse into the water as ... Florida professor who has spent years studying the harmful contaminants that ...
... other non-terminal, debilitating conditions and diseases is both feasible ... such test on the approach in patients with advanced ... edition of the Proceedings of the National Academy of ... the potential to block the destructive inflammation process that ...
Cached Biology News:The roots of civilization trace back to ... roots 2Toxic flood lifts lid on common urban pollution problem 2Toxic flood lifts lid on common urban pollution problem 3Results of world's first gene therapy trial for arthritis show approach safe, feasible 2Results of world's first gene therapy trial for arthritis show approach safe, feasible 3Results of world's first gene therapy trial for arthritis show approach safe, feasible 4
(Date:10/25/2014)... 24, 2014 This research report ... Starch Based Plastics, Regenerated Cellulose, PCL), by Application ... and Forecasts to 2019”, defines and segments the ... forecast of its global volume and value. , ... spread through 178 Slides and in-depth TOC on ...
(Date:10/25/2014)... SonaCare Medical, LLC, leader in ... announced that its Board of Directors has appointed ... President and member of the Board effective immediately. ... expanded responsibilities within the company, including further developing ... commercialization, manufacturing and finance. , Dr. Carol ...
(Date:10/25/2014)... Great Barrington, MA (PRWEB) October 25, 2014 ... contamination control products, is pleased to announce the ... to achieve the highest level of contamination containment ... in ISO Class 3 and higher cleanroom environments, ... continuous filament polyester knit laundered wiper that continues ...
(Date:10/25/2014)... NEW YORK , Oct. 24, 2014 ... Access Pharmaceuticals, Inc. (ACCP), a biopharmaceutical company advancing ... implemented a 1-for-50 reverse split of its common ... Friday, October 24, 2014. PlasmaTech,s common stock will ... number 72754H109 and temporary ticker symbol "ACCPD". After ...
Breaking Biology Technology:Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 2Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 3Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 4SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change and Launches New Corporate Website 2
... April 8 ImQuest Life Sciences presented their ... their novel small molecule piperazine compound for the ... Therapeutics meeting held in Whistler, British Columbia. The ... lead microtubule inhibitor, IQP-0304. The piperazines demonstrate potent ...
... 8 Micromet, Inc. (Nasdaq: MITI ... for the treatment of cancer, inflammation and autoimmune ... the peer-reviewed Journal of Immunotherapy (1) demonstrating the ... to carcinoembryonic antigen (CEA) and to CD3 on ...
... 7 Pharmatech Oncology, Inc., a Research Management Organization ... companies at the Company Showcase during BIOZONA 2009 - ... Downtown on April 7th in Phoenix, Arizona.Matthew B. Wiener, ... during the first session of the conference. The ...
Cached Biology Technology:ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 3Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 4Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA 2
MAb to Vasopressin Preservative: NaN3...
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
Biology Products: